Pacific Therapeutics Limited Common Shares (Canada) (PK:PCFTF)
Business Focus: N/A
Feb 01, 2017 09:01 am ET
Tower One provides corporate update from Colombia
Tower One Wireless Corp (CSE: TO) (CSE: TO.CN) (OTC: PCFTF) (FRANKFURT: A2AFT9) (the "Company") announces that it has received a corporate update from its wholly owned subsidiary, Tower Three SAS (the "T3"), a South American telecommunications infrastructure developer. The company has built seven towers in Colombia and is currently working to expand the collocation of its existing tower portfolio. Collocation on a tower means that antennas from more than one telecom carrier will be deployed or mounted on a single tower. The company is now in advanced stage negotiations
Feb 01, 2017 08:59 am ET
Tower One provides corporate update from Colombia
Tower One Wireless Corp (CSE:TO) (CSE:TO.CN) (OTC:PCFTF) (FRANKFURT:A2AFT9) (the "Company") announces that it has received a corporate update from its wholly owned subsidiary, Tower Three SAS (the "T3"), a South American telecommunications...
Oct 20, 2016 03:32 pm ET
PT Therapeutics Ltd. Enters Into Definitive Agreement With Tower Three SAS
VANCOUVER, British Columbia, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Pacific Therapeutics Ltd. (CSE:PT) (OTC:PCFTF) (Frankfurt:A2AFT9) (“PT” or the “Company”) announces that it has entered into a binding arm’s length share exchange agreement (the “Definitive Agreement”) with Tower Three SAS (“Tower Three”), pursuant to which PT will acquire all of the issued and outstanding securities (the “Tower Three Shares”) of Tower Three (the “Transaction”), as more particularly described below. The Transaction was initially announced in a PT news release dated August 2, 2016, indicating that PT and Tower T...
Oct 14, 2016 10:21 pm ET
Pacific Therapeutics Ltd. Announces Completion of Plan of Arrangement
Pacific Therapeutics Ltd. (CSE: PT)(OTC PINK: PCFTF)(FRANKFURT: A2AFT9) ("PT" or the "Company") announces that the previously announced plan of arrangement (the "Arrangement") with Cabbay Holdings Corp. has completed. The Company set the effective date for the Arrangement with Cabbay Holdings Corp. as October 3, 2016 and set the share distribution record date for the Arrangement as March 11, 2016, which is the record date for shareholders of the Company to receive shares pursuant to the Arrangement. In connection with the Arrangement, $435,359.55 of indebtedness
Oct 14, 2016 10:20 pm ET
Pacific Therapeutics Ltd. Announces Completion of Plan of Arrangement
Pacific Therapeutics Ltd. (CSE:PT)(OTC PINK:PCFTF)(FRANKFURT:A2AFT9) ("PT" or the "Company") announces that the previously announced plan of arrangement (the "Arrangement") with Cabbay Holdings Corp. has completed. The Company set the effective...
Oct 13, 2016 08:30 am ET
Pacific Therapeutics Increases Private Placement
Pacific Therapeutics Ltd. (CSE: PT)(OTC PINK: PCFTF)(FRANKFURT: A2AFT9) (the "Company") announces changes to the previously announced (August 2, 2016) private placement in connection with its proposed transaction (the "Transaction") with Tower Three SAS (the "T3"), a South American. The company will be increases the minimum raise from $750,000 to $1,500,00 and increases the maximum to $2,250,000 at an intended price of $0.15 per Unit.
Oct 13, 2016 08:28 am ET
Pacific Therapeutics Increases Private Placement
Pacific Therapeutics Ltd. (CSE:PT)(OTC PINK:PCFTF)(FRANKFURT:A2AFT9) (the "Company") announces changes to the previously announced (August 2, 2016) private placement in connection with its proposed transaction (the "Transaction") with Tower Three...
Sep 26, 2016 08:30 am ET
Pacific Therapeutics Receives Revenue Update from Tower Three
Pacific Therapeutics Ltd. (CSE: PT)(OTC PINK: PCFTF)(Frankfurt: 1P3) (the "Company") announces that it has received a corporate update regarding its proposed transaction (the "Transaction") with Tower Three SAS (the "T3"), a South American telecommunications infrastructure developer. T3 has received its first rental payment from a major telecom provider (the "Anchor Tenant") for use of three towers out of the first ten tower development. The Company has received information that T3's fourth and fifth towers are expected to be completed and connected
Sep 26, 2016 08:28 am ET
Pacific Therapeutics Receives Revenue Update from Tower Three
Pacific Therapeutics Ltd. (CSE:PT)(OTC PINK:PCFTF)(Frankfurt:1P3) (the "Company") announces that it has received a corporate update regarding its proposed transaction (the "Transaction") with Tower Three SAS (the "T3"), a South American...
Aug 02, 2016 09:29 am ET
Pacific Therapeutics Plans to Acquire Tower Three Wireless SAS
Pacific Therapeutics Ltd. (CSE:PT) (OTC PINK:PCFTF) (FRANKFURT:1P3) (the "Company" or "PT"), announces that it has entered into a letter of intent (the "LOI") with Tower Three Wireless SAS ("TOWERTHREE") to acquire all of the issued and outstanding...
Aug 02, 2016 09:29 am ET
Pacific Therapeutics Plans to Acquire Tower Three Wireless SAS
Pacific Therapeutics Ltd. (CSE: PT) (OTC PINK: PCFTF) (FRANKFURT: 1P3) (the "Company" or "PT"), announces that it has entered into a letter of intent (the "LOI") with Tower Three Wireless SAS ("TOWERTHREE") to acquire all of the issued and outstanding membership interests of TOWERTHREE (the "Transaction"). The Company will have until October 30, 2016 to conduct due diligence on TOWERTHREE, with a view to negotiating the terms of a definitive agreement in order to complete the Transaction.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
